GRAFT POLYMER (UK) PLC

AGM Information • Apr 28, 2025

PRINT OF RESOLUTION

OF

SOLVONIS THERAPEUTICS PLC (the "Company")

Passed 28 April 2025

At the general meeting of the Company, duly convened and held at 11:00 a.m. on 28 April 2025 at EP-25, Eccleston Yards, 25 Eccleston Place, London SW1W 9NF, the following resolutions were passed:

ORDINARY RESOLUTION

RESOLUTION 1 - ALLOTMENT OF ORDINARY SHARES

THAT, subject to and conditional upon the passing of resolution 2, in accordance with section 551 of the Companies Act 2006 (the "Act"), the directors of the Company be and are generally and unconditionally authorised under section 551 of the Act to exercise all powers of the Company to allot shares in the Company and to grant rights to subscribe for or to convert any security into, shares of the Company (such shares, and rights to subscribe for or to convert any security into shares of the Company being ("relevant securities")) up to a maximum aggregate nominal amount of

(a) £2,777,844.024 (being equal to 2,777,844,024 ordinary shares of £0.001 in the capital of the Company ("Ordinary Shares")) in connection with the Proposed Acquisition (as defined in the document of which this notice of general meeting ("Notice") forms part); and

(b) £4,722,155.97 (in addition to the authorities conferred in sub-paragraph (a) above) being equal to 4,722,155,976 Ordinary Shares, provided that (unless previously renewed, revoked, varied or extended by the Company at a general meeting), these authorities shall expire at the end of the next annual general meeting of the Company to be held after the date of the passing of this resolution, save that the Company may at any time before such expiry make an offer or agreement which would or might require relevant securities to be allotted after such expiry and the directors may allot relevant securities under such an offer or agreement as if the authority granted by this resolution had not expired.

SPECIAL RESOLUTION

RESOLUTION 2 - DISAPPLICATION OF PRE-EMPTION RIGHTS

THAT, subject to and conditional on the passing of resolution 1, and in addition to any existing authorities and powers given to the directors under section 570 of the Act, the directors of the Company be empowered under section 571(1) of the Act, to allot equity securities (as defined in section 560 of the Act) of the Company for cash pursuant to the authorities conferred by resolution 1, as if section 561(1) of the Act did not apply to such allotment provided that this power shall be limited to the allotment of equity securities up to a maximum aggregate nominal amount of:

(a) £2,777,844.024 (being equal to 2,777,844,024 Ordinary Shares) in connection with the Proposed Acquisition (as defined in the document of which this Notice forms part), and

(b) £4,722,155.97 (in addition to the authorities conferred in sub-paragraph (a) above) being equal to 4.722.155.976 Ordinary Shares, provided (unless previously renewed, revoked varied or extended by the Company at a general meeting), this authority shall expire at the next annual general meeting of the Company to be held after the date of the passing of this resolution, save that the Company may at any time before such expiry make an offer or agreement which would or might require equity securities to be allotted after such expiry and the directors may allot equity securities in pursuance of such an offer or agreement as if the authority granted by this resolution had not expired.

now

Chairperson